In order to obtain this action we must pay 16,70$ right now, Orchard Therapeutics PLC, with address at 108 CANNON STREET, LONDON, EC4N 6EU, United Kingdom, is a publicly traded company and its visible heads at the moment are Adrien Lemoine (Chief Business Officer), Andrea Spezzi (Chief Medical Officer), Bobby Gaspar (Chief Executive Officer & Executive Director), Frank E. Thomas (President, COO, CFO & Chief Accounting Officer), Leslie Meltzer (Chief Medical Officer), Nicoletta Loggia (Chief Technical Officer), Ran Zheng (Chief Technical Officer). Focused on Biotechnology: Biological Products (No Diagnostic Substances) was created long ago in United Kingdom.

Today this action begins with yesterday's closing price, desconocido$.

The current range on the same day is from 16,64$ - 16,72$, with a percentage difference of 16,68$ quite wide that helps to be able to do day trading.

The company has an annual revenue of desconocido.

The last registered opening is of desconocido.

One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.

EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].